Read More 2 minute read Pharma Industry News Arkuda Therapeutics gets $64m booster to advance neurodegenerative treatment Arkuda Therapeutics, a US-based biotechnology company, has raised $64 million in Series B financing. The new funding will… bySrinathFebruary 11, 2022